The 1 analysts offering 12-month price forecasts for KemPharm Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +244.83% increase from the last price of 0.44.
The current consensus among 1 polled investment analysts is to Buy stock in KemPharm Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.00
Reporting Date Aug 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.